Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Science Translational Medicine
|
November 9, 2012
Human melanoma metastasis in NSG mice correlates with clinical outcome in patients
Elsa Quintana, Elena Piskounova, Mark Shackleton, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 11, 2009
iNOS-derived nitric oxide mediates the increase in TFF2 expression associated with gastric damage: role of HIF-1
Dolores Ortiz-Masiá, Carlos Hernández, Elsa Quintana, et al.
Nature Communications
|
August 23, 2016
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Ugur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
The Journal of Investigative Dermatology
|
March 12, 2014
Merkel cell carcinoma dependence on bcl-2 family members for survival
Monique E Verhaegen, Doris Mangelberger, Jack W Weick, et al.
Nature Communications
|
September 30, 2016
Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Ugur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Nature Communications
|
September 25, 2024
Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade
Panayiotis Anastasiou, Christopher Moore, Sareena Rana, et al.
Cancer Research
|
May 1, 2020
Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment
Elsa Quintana, Christopher J Schulze, Darienne R Myers, et al.
Cancer Discovery
|
March 9, 2025
T-cell dependency of tumor regressions and complete responses with RAS(ON) multi-selective inhibition in preclinical models of PDAC
Margo I Orlen, William P Vostrejs, Rina Sor, et al.
Cancer Immunology Research
|
November 4, 2025
RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma
Larissa Anastacio Da Costa Carvalho, Nataliya Tovbis Shifrin, Manali S Phadke, et al.
Frontiers in Immunology
|
November 2, 2020
Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity
Darienne R Myers, Clare L Abram, David Wildes, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Science Translational Medicine
|
November 9, 2012
Human melanoma metastasis in NSG mice correlates with clinical outcome in patients
Elsa Quintana, Elena Piskounova, Mark Shackleton, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 11, 2009
iNOS-derived nitric oxide mediates the increase in TFF2 expression associated with gastric damage: role of HIF-1
Dolores Ortiz-Masiá, Carlos Hernández, Elsa Quintana, et al.
Nature Communications
|
August 23, 2016
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Ugur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
The Journal of Investigative Dermatology
|
March 12, 2014
Merkel cell carcinoma dependence on bcl-2 family members for survival
Monique E Verhaegen, Doris Mangelberger, Jack W Weick, et al.
Nature Communications
|
September 30, 2016
Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Ugur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Nature Communications
|
September 25, 2024
Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade
Panayiotis Anastasiou, Christopher Moore, Sareena Rana, et al.
Cancer Research
|
May 1, 2020
Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment
Elsa Quintana, Christopher J Schulze, Darienne R Myers, et al.
Cancer Discovery
|
March 9, 2025
T-cell dependency of tumor regressions and complete responses with RAS(ON) multi-selective inhibition in preclinical models of PDAC
Margo I Orlen, William P Vostrejs, Rina Sor, et al.
Cancer Immunology Research
|
November 4, 2025
RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma
Larissa Anastacio Da Costa Carvalho, Nataliya Tovbis Shifrin, Manali S Phadke, et al.
Frontiers in Immunology
|
November 2, 2020
Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity
Darienne R Myers, Clare L Abram, David Wildes, et al.
Page
of 4